SurModics
SRDX
#6744
Rank
โ‚ฌ0.53 B
Marketcap
37,44ย โ‚ฌ
Share price
0.00%
Change (1 day)
3.84%
Change (1 year)
Categories

EPS for SurModics (SRDX)

EPS in 2025 (TTM): -1,11ย โ‚ฌ

According to SurModics's latest financial reports the company's current EPS (TTM) is -1,07ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -0,88ย โ‚ฌ a decrease over its 2023 EPS that were of 0,34ย โ‚ฌ.

EPS history for SurModics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-1,11ย โ‚ฌ26.41%
2024-0,88ย โ‚ฌ-358.97%
20230,34ย โ‚ฌ-116.81%
2022-2,02ย โ‚ฌ-1884.62%
20210,11ย โ‚ฌ160%
20200,04355ย โ‚ฌ-89.58%
20190,42ย โ‚ฌ-536.36%
2018-0,09581ย โ‚ฌ
2017N/A-100%
20160,64ย โ‚ฌ-23.16%
20150,83ย โ‚ฌ7.95%
20140,77ย โ‚ฌ-13.73%
20130,89ย โ‚ฌ41.67%
20120,63ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
9,70ย โ‚ฌ-1,005.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
3,27ย โ‚ฌ-404.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
15,48ย โ‚ฌ-1,544.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Agilent Technologies
A
3,99ย โ‚ฌ-472.36%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
6,71ย โ‚ฌ-726.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
1,80ย โ‚ฌ-268.29%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Nektar Therapeutics
NKTR
-6,94ย โ‚ฌ 547.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Heron Therapeutics
HRTX
-0,06968ย โ‚ฌ-93.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-0,18ย โ‚ฌ-82.93%๐Ÿ‡บ๐Ÿ‡ธ USA